Regencell Bioscience Holdings Limited
RGC
Rang în acțiuni
#3427
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Preț acțiune
$9.98
Capitalizare de piață
$4.95B
Schimbare (1 zi)
4.07%
Schimbare (1 an)
-42.68%
Țară
HK
Tranzacționează Regencell Bioscience Holdings Limited (RGC)
Categorie
Healthcare
EPS pentru Regencell Bioscience Holdings Limited (RGC)
EPS la data de June 2026 TTM: $-0.02
Conform celor mai recente rapoarte financiare și prețului acțiunilor Regencell Bioscience Holdings Limited, EPS-ul actual al companiei (TTM) este $-0.02. La sfârșitul anului 2024, compania avea un EPS de $-0.01 egal cu EPS-ului din 2023, care a fost de $-0.01.
Istoricul EPS pentru Regencell Bioscience Holdings Limited din 2019 până în 2026
EPS la sfârșitul fiecărui an
| An | EPS | Schimbă |
|---|---|---|
| 2026 (TTM) | $-0.02 | 136.00% |
| 2025 | $-0.01 | -17.24% |
| 2024 | $-0.01 | -26.89% |
| 2023 | $-0.01 | -20.67% |
| 2022 | $-0.02 | 435.71% |
| 2021 | 0.00 | 64.71% |
| 2020 | 0.00 | 112.50% |
| 2019 | 0.00 | 0.00% |
EPS pentru companii similare sau concurente
| Companie | EPS | Diferență EPS | Țara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -2,457.20% |
IN
|
